🇺🇸 FDA
Patent

US 6462038

Androgen receptor modulator compounds and methods

expired A61PA61P13/08A61P15/08

Quick answer

US patent 6462038 (Androgen receptor modulator compounds and methods) held by Ligand Pharmaceuticals Incorporated expires Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Oct 08 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
69
CPC classes
A61P, A61P13/08, A61P15/08, A61P15/10, A61P15/16